Time
Days to earnings26
Next print2026-11-17
WindowBMO
Fiscal2026-10-31
| Date | DTE | Next | Close | Cons. EPS | IV front % | Implied | Ret 5d | Ret 10d | Ret 20d | Ret 30d | EPS high / low | Dispersion | Analysts | P/C | Peers rpt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-12 | 26 | 2026-11-17 | 91.82 | 1.332 | 41.5% | 13.0% | +4.4% | +2.6% | -2.1% | +0.6% | 1.34 / 1.32 | 1.5% | 24 | 0.65 | 0 | |
| 2026-10-09 | 27 | 2026-11-17 | 88.52 | 1.331 | 41.5% | 13.6% | +2.5% | -0.1% | -2.7% | -1.6% | 1.34 / 1.32 | 1.5% | 23 | 0.62 | 0 | |
| 2026-10-08 | 28 | 2026-11-17 | 87.75 | 1.331 | 35.1% | 11.6% | +1.5% | -0.9% | -4.2% | -4.6% | 1.34 / 1.32 | 1.5% | 23 | 0.63 | 0 | |
| 2026-10-07 | 29 | 2026-11-17 | 85.49 | 1.331 | 38.1% | 12.8% | -0.9% | -4.3% | -7.0% | -6.2% | 1.34 / 1.32 | 1.5% | 23 | 0.59 | 0 | |
| 2026-10-06 | 30 | 2026-11-17 | 87.10 | 1.331 | 31.7% | 10.8% | +0.0% | -4.0% | -5.7% | -6.2% | 1.34 / 1.32 | 1.5% | 23 | 0.58 | 0 | |
| 2026-10-05 | 31 | 2026-11-17 | 87.98 | 1.331 | 34.2% | 11.7% | -1.7% | -4.1% | -6.6% | -5.8% | 1.34 / 1.32 | 1.5% | 23 | 0.53 | 0 | |
| 2026-10-02 | 32 | 2026-11-17 | 86.36 | 1.331 | 36.1% | 12.8% | -2.6% | -6.3% | -7.2% | -6.4% | 1.34 / 1.32 | 1.5% | 20 | 0.54 | 0 | |
| 2026-10-01 | 33 | 2026-11-17 | 86.47 | 1.331 | 40.0% | 14.4% | -2.3% | -6.8% | -6.2% | -8.1% | 1.34 / 1.32 | 1.5% | 20 | 0.55 | 0 | |
| 2026-09-30 | 34 | 2026-11-17 | 86.26 | 1.331 | 40.5% | 14.7% | -3.4% | -6.8% | -6.3% | -6.3% | 1.34 / 1.32 | 1.5% | 20 | 0.59 | 0 | |
| 2026-09-29 | 35 | 2026-11-17 | 87.09 | 1.331 | 35.6% | 13.1% | -4.1% | -7.1% | -3.9% | -3.9% | 1.34 / 1.32 | 1.5% | 20 | 0.61 | 0 |
Linked names and their last print
| Peer | Name | Score | Last qtr | Last surprise | Reaction | 1-day close | DTE (full) |
|---|---|---|---|---|---|---|---|
| SYK primary | Stryker Corporation | 0.61 | 2026Q2 · 2026-07-30 | +6.6% | -5.2% | 325.70 | 13 · 2026-10-12 |
| ABT primary | Abbott Laboratories | 0.55 | 2026Q2 · 2026-07-16 | +2.3% | +6.7% | 98.83 | 7 · 2026-10-12 |
| BSX primary | Boston Scientific Corp | 0.46 | 2026Q2 · 2026-07-29 | +3.6% | -7.4% | 46.04 | 12 · 2026-10-12 |
| ISRG primary | Intuitive Surgical Inc | 0.41 | 2026Q2 · 2026-07-16 | +38.6% | -9.3% | 345.42 | 7 · 2026-10-09 |
| Fiscal qtr | Report date | Window | Actual EPS | Surprise % | Beat | Reaction | 1-day result | Vol ×10d | Post 10d | Review |
|---|---|---|---|---|---|---|---|---|---|---|
| 2027Q1 | 2026-09-01 | BMO | 1.45 | +4.3% | Beat | +1.5% | -2.1% | 2.62× | +0.6% | Review |
| 2026Q4 | 2026-06-03 | BMO | 1.55 | +0.6% | Beat | +4.6% | +1.1% | 1.71× | +0.2% | Review |
| 2026Q3 | 2026-02-17 | BMO | 1.36 | +1.5% | Beat | -3.6% | +0.6% | 1.83× | +0.3% | Review |
| 2026Q2 | 2025-11-18 | BMO | 1.36 | +3.8% | Beat | +3.8% | +0.8% | 3.32× | +1.2% | Review |
| 2026Q1 | 2025-08-19 | BMO | 1.26 | +2.4% | Beat | -5.4% | +2.4% | 2.80× | +2.6% | Review |
| 2025Q4 | 2025-05-21 | BMO | 1.62 | +2.5% | Beat | +0.3% | -2.5% | 1.88× | +3.1% | Review |
| 2025Q3 | 2025-02-18 | BMO | 1.39 | +2.2% | Beat | -5.2% | -2.1% | 2.32× | +8.1% | Review |
| 2025Q2 | 2024-11-19 | BMO | 1.26 | +0.8% | Beat | -1.8% | -1.2% | 1.66× | +0.4% | Review |
| 2025Q1 | 2024-08-20 | BMO | 1.23 | +2.5% | Beat | -1.0% | +1.6% | 2.10× | +6.6% | Review |
| 2024Q4 | 2024-05-23 | BMO | 1.46 | +0.7% | Beat | -2.6% | -2.6% | 1.88× | +3.3% | Review |